Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)
← catalyst calendarSponsored by Nyxoah S.A. (industry) · NYXH.BR — their whole pipeline →. With Nyxoah Inc..
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
115estimated
Sites
21
Countries
Australia, Belgium, Germany +1
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-10-14 | actual | When the study began enrolling |
| Primary completion | 2024-02-20 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Feb 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2019-03-11 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-14 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Obstructive Sleep Apnea
Intervention
- Device: Genio™ system
Primary outcomes
what the primary-completion date above is the date OFChange in Apnea Hypopnea Index (AHI4%)
measured 12 months
Change in Oxyhemoglobin Desaturation Index (ODI4%)
measured 12 months
Publications
- PMID 40702817 — linked by the registry
- PMID 39806685 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · NYXH.BR's whole pipeline · Catalyst calendar · Every registered study · What changed